Serum neurofilament light-chain (sNfL) levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (RRMS) patients in the CombiRx trial

被引：0
|
作者：
Cutter, Gary [1 ]
Rudick, Richard A. [2 ]
De Moor, Carl [2 ]
Singh, Carol M. [2 ]
Fisher, Elizabeth [2 ]
Lublin, Fred D. [3 ,4 ]
Wolinsky, Jerry S. [5 ]
McFarland, Henry [6 ]
Jacobson, Steven [7 ]
Naylor, Maria L. [2 ]
机构：
[1] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA
[2] Biogen, Cambridge, MA USA
[3] Icahn Sch Med Mt Sinai, Dept Neurol, Corinne Goldsmith Dickinson Ctr Multiple Scleros, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA
[5] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[6] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA
[7] Natl Inst Neurol Disorders & Stroke, Viral Immunol Sect, NIH, Bethesda, MD USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2410
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Can serum neurofilament light chain testing be useful for therapeutic decisions in relapsing-remitting multiple sclerosis with cognitive impairment?
    Garcia Dominguez, Jose Manuel
    Gomez, Rocio
    Querol, Luis
    Lallana, Jose Meca
    Landete, Lamberto
    Meca, Virginia
    Villar Guimerans, Luisa Maria
    Martinez Yelamos, Sergio
    Elena Garcia, Maria
    Aguera Morales, Eduardo
    Maurino, Jorge
    Caminero Rodriguez, Ana Belen
    Medrano, Nicolas
    Monreal, Enric
    Saposnik, Gustavo
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 972 - 973
  • [32] Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
    Kuhle, Jens
    Plavina, Tatiana
    Barro, Christian
    Disanto, Giulio
    Sangurdekar, Dipen
    Singh, Carol M.
    de Moor, Carl
    Engle, Bob
    Kieseier, Bernd C.
    Fisher, Elizabeth
    Kappos, Ludwig
    Rudick, Richard A.
    Goyal, Jaya
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (13) : 1691 - 1699
  • [33] Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis
    Comabella, Manuel
    Sastre-Garriga, Jaume
    Carbonell-Mirabent, Pere
    Fissolo, Nicolas
    Tur, Carmen
    Malhotra, Sunny
    Pareto, Deborah
    Aymerich, Francesc X.
    Rio, Jordi
    Rovira, Alex
    Tintore, Mar
    Montalban, Xavier
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (07): : 732 - 740
  • [34] Relapsing-remitting multiple sclerosis: a long-term observation of immunomodulatory therapy
    Romanowski, F
    Straube, E
    Heinemann, J
    Rhein, R
    JOURNAL OF NEUROLOGY, 2004, 251 : 152 - 152
  • [35] Long-term adherence to interferon β therapy in relapsing-remitting multiple sclerosis
    Portaccio, E.
    Zipoli, V.
    Siracusa, G.
    Sorbi, S.
    Amato, M. P.
    EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 131 - 135
  • [36] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Ashtamker, N.
    Sidi, Y.
    Ladkani, D.
    Gorfine, T.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 39 - 39
  • [37] Long-Term Efficacy, Safety and Tolerability of Ponesimod in Patients with Relapsing-Remitting Multiple Sclerosis
    Freedman, Mark
    Boster, Aaron
    Fernandez, Oscar
    Melanson, Maria
    Pozzilli, Carlo
    D'Ambrosio, Daniele
    Sidorenko, Tatiana
    Olsson, Tomas
    NEUROLOGY, 2013, 80
  • [38] Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial
    Hauser, Stephen
    Kappos, Ludwig
    Li, David
    Calabresi, Peter
    O'Connor, Paul
    Bar-Or, Amit
    Barkhof, Frederik
    Wells, Chris
    Leppert, David
    Glanzman, Robert
    Tinbergen, Jeroen
    NEUROLOGY, 2012, 78
  • [39] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Lublin, F. D.
    Dadon, Y.
    Gorfine, T.
    Davis, M. D.
    Sorensen, P. S.
    Knappertz, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 122 - 123
  • [40] The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis
    Derfuss, T.
    Sastre-Garriga, J.
    Montalban, X.
    Rodegher, M.
    Wuerfel, J.
    Gaetano, L.
    Tomic, D.
    Azmon, A.
    Wolf, C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (01)
12345